KIMBERLY JOHNSON: Open Payments
NPI 1861891616 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 6 companies in 2025. Trend: 2023 $281 · 2024 $252 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $83 |
| Amgen Inc. | 4 | $73 |
| Kestra Medical Technology Services, Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $33 |
| PFIZER INC. | 1 | $23 |
Products named: CARDIOMEMS, REPATHA, Assure WCD, LEQVIO, SAPIEN 3 Ultra RESILIA, ELIQUIS.
Industry payments across IN — which companies pay providers there.
